Enterprise Pharmacy Forward

Sign in Subscribe

Medication Safety

Tenecteplase is here: Navigating the shift of a stroke thrombolytic in the United States prior to FDA approval: a mini-review on rationale, barriers and pathways

Tenecteplase is here: Navigating the shift of a stroke thrombolytic in the United States prior to FDA approval: a mini-review on rationale, barriers and pathways

Julian M. Burwell, Jason R. Howay, Lisa Wasko, Samantha Doucoure, Jamie L. Kerestes, Clemens M. Schirmer, David Ermak, Anthony Noto, Philipp Hendrix Until March 2025, alteplase (TPA) was the sole thrombolytic agent approved by the U.S. Food and Drug Administration (FDA) for the treatment of acute ischemic stroke (AIS)

Restoring cleanroom integrity: HVAC renovations at 2 primary compounding locations

Adam Castro In 2024, Geisinger completed critical heating, ventilation and air conditioning (HVAC) renovations at 2 of its primary sterile compounding locations — Geisinger Wyoming Valley (GWV) operating rooms and Geisinger Medical Center (GMC) Hematology/Oncology Biologics Pharmacy suite. These upgrades addressed longstanding environmental control challenges that directly impacted sterile compounding

Geisinger Pharmacy services: Our integrated pharmacy network

Stephanie Gill Geisinger’s integrated pharmacy network continues to support high-quality, cost-effective, evidence-based medication therapy management across central, south-central and northeastern Pennsylvania. Serving more than 1 million residents in 45 counties, the network includes 50+ pharmacy locations encompassing inpatient, outpatient, ambulatory care, home infusion and mail-

Standardizing Broselow carts: Elevating pediatric emergency care across Geisinger

Emma Wysocki Since their development in the 1980s, Broselow carts have revolutionized pediatric emergency medicine by streamlining access to lifesaving equipment and supplies. Broselow carts are organized into color-coded drawers that correspond to specific length and weight ranges and have consistently demonstrated several advantages over standard code carts in

Unlocking the power of pharmacogenomics: MyCode’s role in safer, smarter prescribing

Unlocking the power of pharmacogenomics: MyCode’s role in safer, smarter prescribing

Ryley Uber The Geisinger MyCode® Community Health Initiative has been underway for nearly 2 decades, positively influencing our understanding of how genomics affect health while enabling pathways for clinical confirmation of genomic results. Yet a key question remains: How can MyCode pharmacogenomic (PGx) data be used to improve medication outcomes

Medication reconciliation transformation: Enhancing safety across the care continuum

Brian Simpkins Geisinger has launched a multi-phase initiative to improve medication reconciliation processes across the system, with a focus on strengthening patient safety and care continuity from admission through discharge. The effort addresses longstanding challenges related to medication accuracy, workflow consistency and system integration. The initial phase targets transitions